Education
About Us
Working with TipRanks
Follow Us
Tracey L McCain Insider Profile
4 Followers
Tracey L McCain, EVP & CLO at Blueprint Medicines, holds 66.58K shares in Blueprint Medicines (Ticker: BPMC), holds 9.37K shares in Kiniksa Pharmaceuticals (Ticker: KNSA), holds ― shares in ImmunoGen (Ticker: IMGN). Most recently, Tracey L McCain Sold ― shares of Blueprint Medicines on Mar 07, 2025 for an estimated value of 467.27K.
Profitable Transactions
3 out of 6 Profitable Transactions
Average Return
-24.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Tracey L McCain holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Mar 05, 2021 - Mar 05, 2022
Return:+40.50%
The most profitable trade made by Tracey L McCain
Tracey L McCain's Trading History
Blueprint Medicines
Mar 07, 2025
EVP & CLO
Informative Sell
467.27K
$5.80M
Kiniksa Pharmaceuticals
Jun 07, 2024
Director
Uninformative Buy
85.36K
$201.61K
ImmunoGen
―
―
―
―
List of latest transactions for each holding click on a transaction to see Tracey L McCain's performance on stock
You May Also Like
Tracey L McCain insider profile FAQ
What is the percentage of profitable transactions made by Tracey L McCain?
The percentage of profitable transactions made by Tracey L McCain is 50%.
What is the average return per transaction made by Tracey L McCain?
The average return per transaction made by Tracey L McCain is -24.50%.
What stocks does Tracey L McCain hold?
Tracey L McCain holds: BPMC, KNSA, IMGN stocks.
What was Tracey L McCain’s latest transaction?
Tracey L McCain latest transaction was an Informative Sell of $467.27K.
What was Tracey L McCain's most profitable transaction?
Tracey L McCain’s most profitable transaction was an Informative Sell of BPMC stock on March 5, 2021. The return on the trade was 40.50%.
What is Tracey L McCain's role in Blueprint Medicines?
Tracey L McCain's role in Blueprint Medicines is EVP & CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.